Document Detail


Comparison of nuchal translucency measurement and second-trimester triple serum screening in twin versus singleton pregnancies.
MedLine Citation:
PMID:  10451516     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Maternal serum screening for Down syndrome (DS) in twin pregnancies poses difficulties due to a lack of precise biochemical information about each co-twin. The current study attempts, for the first time, to compare two screening methods: nuchal translucency (NT) measurement and serum screening for DS, in twin pregnancies. 60 women with twin pregnancies (study group) underwent both first-trimester NT scanning and mid-trimester triple-marker serum screening, and were followed throughout their gestation. Nuchal translucency measurements were compared with a matched control of 120 singleton pregnancies with a similar (+/-2 years) maternal age and fetal crown-rump length (CRL) (+/-3 mm). In both analyses, a risk of 1:380, or higher, of having a DS newborn was considered screen positive. Both mean maternal age (31+/-3 years) and CRL (62+/-11 mm) were similar in the study and control groups. The median NT measurement expressed as multiples of the median (MOM) for CRL was similar in the study and control groups (0.85 and 0.88, respectively). Based on NT measurements, 5 per cent of the pregnancies in the study group and 2.5 per cent in the control group were defined as screen positive (p =N. S). Mid-gestation serum screening was associated with 15 per cent and 6 per cent screen-positive rate in study and control groups, respectively (p<0. 05). There was a ratio of 1:3 screen-positive rate between first and second-trimester screening tests within the study group. This high false-positive rate results led to 18.3 per cent amniocentesis rate in the study group compared with 7.5 per cent of the control group (p<0.03). Only one co-twin which was picked up by the NT screen was further diagnosed as trisomy 21, and one co-twin with cardiac and neural tube defect was missed by the two screening tests and was later picked up in an anomaly scan. Although the current series is too small to provoke any changes in screening practice, when twin pregnancies are diagnosed, it seems very reasonable to offer them NT measurement. A larger group may be needed to clarify which approach is the most beneficial screening policy for this highly selected group of pregnant women.
Authors:
R Maymon; E Dreazen; S Rozinsky; I Bukovsky; Z Weinraub; A Herman
Related Documents :
18186146 - Use of the combined first-trimester screen result and low papp-a to predict risk of adv...
23029616 - The fetal origins of the metabolic syndrome: can we intervene?
20832736 - Screening for hyperglycaemia in pregnancy: consensus and controversy.
6858616 - Estriol screening in pregnancy. prognostic value of total estriol in serum (e3) in an o...
17827166 - Expression of prostasin serine protease and protease nexin-1 (pn-1) in rhesus monkey ov...
23610036 - Value of transvaginal sonography in diagnosing heterotopic pregnancy after in-vitro fer...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  19     ISSN:  0197-3851     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  1999 Aug 
Date Detail:
Created Date:  1999-11-09     Completed Date:  1999-11-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  727-31     Citation Subset:  IM    
Copyright Information:
Copyright 1999 John Wiley & Sons, Ltd.
Affiliation:
Department of Obstetrics and Gynecology, Assaf Harofe Medical Center, Zerifin, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Biological Markers / blood*
Case-Control Studies
Down Syndrome / blood*,  ultrasonography*
Female
Humans
Predictive Value of Tests
Pregnancy
Pregnancy Trimester, First
Pregnancy Trimester, Second
Pregnancy, Multiple*
Twins
Ultrasonography, Prenatal*
Chemical
Reg. No./Substance:
0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prenatal diagnosis of supernumerary marker 15 chromosomes and exclusion of uniparental disomy for ch...
Next Document:  Technical factors in early amniocentesis predict adverse outcome. Results of the Canadian Early (EA)...